Beam Therapeutics Inc.

Some of the best links we picked up around the internet

CMN Weekly (28 March 2025) - Your Weekly CRISPR...

CMN Weekly

Mar. 28, 2025

Some of the best links we picked up around the internet

CMN Weekly (14 March 2025) - Your Weekly CRISPR...

CMN Weekly

Mar. 14, 2025

Some of the best links we picked up around the internet

Beam Therapeutics Reports Clinical...

CMN Clinical

Mar. 12, 2025

Eight months after dosing the first patient with BEAM-302, Beam Therapeutics has shared exciting safety and efficacy data indicating that a...

CMN Weekly (7 March 2025) - Your Weekly CRISPR...

CMN Weekly

Mar. 7, 2025

Some of the best links we picked up around the internet

CMN Weekly (13 December 2024) - Your Weekly CRISPR...

CMN Weekly

Dec. 13, 2024

Some of the best links we picked up around the internet

CMN Weekly (8 November 2024) - Your Weekly CRISPR...

CMN Weekly

Nov. 8, 2024

Some of the best links we picked up around the internet

CMN Weekly (9 August 2024) - Your Weekly CRISPR...

CMN Weekly

Aug. 9, 2024

Some of the best links we picked up around the internet

Beam Therapeutics Inc.

Glycogen Storage Disease Type Ia, GSDIa, (NCT06735755)
Sponsors:
Beam Therapeutics Inc.

IND Enabling

Phase I

Phase II

Phase III

Alpha 1-Antitrypsin Deficiency, AATD, (NCT06389877)
Sponsors:
Beam Therapeutics Inc.

IND Enabling

Phase I

Phase II

Phase III

Sickle Cell Trait, (NCT06071377)
Sponsors:
National Alliance for Sickle Cell Centers

IND Enabling

Phase I

Phase II

Phase III

T-Cell Acute Lymphoblastic Leukaemia, T-ALL, and Lymphoma, T-LL, (NCT05885464)
Sponsors:
Beam Therapeutics Inc.

IND Enabling

Phase I

Phase II

Phase III

Sickle Cell Disease, SCD, (NCT05456880)
Sponsors:
Beam Therapeutics

IND Enabling

Phase I

Phase II

Phase III